Hypothalamus and Pituitary BSC

Objectives

  • Review case presentations related to ADH (antidiuretic hormone).

  • Correlate signs and symptoms of hypopituitarism to deficiencies in pituitary hormones.

  • Evaluate the causes of hyperprolactinemia.

  • Correlate the metabolic functions of GH (growth hormone) to the clinical features of acromegaly.

  • Differentiate between the actions of GH and IGF-I (insulin-like growth factor I) in acromegaly. Apply the characteristics of disease presentation to either GH or IGF-I effects.

  • Describe appropriate screening tests, as well as identify the appropriate suppression or stimulatory tests for endocrine disorders (based on the physiology of feedback loops).

Physiology Knowledge Check

  • Damage to the pituitary stalk may result in an increase in:

    • A. FSH (Follicle-stimulating hormone)

    • B. GH (Growth Hormone)

    • C. ACTH (Adrenocorticotropic hormone)

    • D. PRL (Prolactin)

    • E. TSH (Thyroid-stimulating hormone)

  • During a fast, GH secretion is stimulated by:

    • F. Insulin

    • G. Glucagon

    • H. Ghrelin

    • I. Somatostatin

    • J. GnRH (Gonadotropin-releasing hormone)

  • The pituitary cell that produces two hormones is:

    • K. Thyrotrope

    • L. Gonadotrope

    • M. Corticotrope

    • N. Somatotrope

  • A 74-year-old patient presents with headaches, difficulty concentrating, impaired memory, muscle cramps, and weakness. Laboratory values report serum sodium of 120 mmol/L. Which would be compatible with a differential diagnosis of syndrome of inappropriate ADH secretion?

    • O. Low plasma AVP (Arginine vasopressin) levels

    • P. Serum osmolarity of 265 mOsm/L

    • Q. Plasma glucose 300 mg/dL

    • R. Urinary osmolarity <400 mOsm/L

Posterior Pituitary Clinical Correlations #1

  • A 32-year-old patient post-concussion showed increased urine output with low urine osmolality 24 hours later.

  • Diagnosis and hormone responsible:

    • Likely diagnosis: Diabetes insipidus.

    • Hormone responsible: ADH deficiency.

Posterior Pituitary Clinical Correlations #2

  • A 56-year-old man with lung cancer and a grand mal seizure has:

    • Serum [Na + ]: 110 mEq/L (normal 140)

    • Urine Osmolarity: 650 mOsm/L (concentrated)

    • Diagnosis: Likely SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion).

  • Treatment: Intravenous infusion of hypertonic NaCl and demeclocycline (ADH antagonist).

Posterior Pituitary Clinical Correlations #3

  • A 27-year-old female developed hypernatremia and increased dilute urine output after head trauma.

  • ADH levels: Decreased.

  • Effects of decreased ADH levels: Increased serum osmolarity, decreased urine osmolarity.

Case #1: Mrs. Omaya

  • Chief Complaint: Extreme fatigue since childbirth 9 months ago.

  • Patient Profile: 25-year-old female, previous good health, problematic lactation post-delivery, amenorrhea, weight retention, changes in skin and voice, history of postpartum hemorrhage requiring transfusion.

  • Vital Signs: T 37°C, BP 100/70 mmHg, P 60/min.

  • Physical Exam: Coarse skin texture, otherwise normal.

Mrs. Omaya’s Symptoms/History

  • Fatigue

  • Unable to lactate

  • Amenorrhea

  • Weight retention

  • Changes in skin and voice post-pregnancy

  • History: Normal pregnancy, postpartum hemorrhage.

Mrs. Omaya’s Laboratory Values

Plasma Concentration

Value

Normal Range

Sodium

130 mmol/L

137-147

Potassium

4.5 mmol/L

3.5-5.3

Chloride

102 mmol/L

99-108

CO2

25 mmol/L

22-28

Glucose (fasting)

62 mg/dL

60-109

Cortisol (8 AM)

3.0 µg/dL

5-25

Free T4

0.4 µg/dL

0.6-1.7

IGF-1

64 ng/mL

90-360

TSH

0.1 µU/ml

0.5-5

Prolactin

3.6 ng/mL

5-25

LH

2.8 mU/mL

5-30

FSH

2.3 mU/mL

5-16

Growth Hormone (GH)

< 0.25 ng/mL

0-10

Sheehan Syndrome

  • Correlating Mrs. Omaya’s symptoms:

    • Inability to lactate → indicate prolactin deficiency.

    • Amenorrhea → due to insufficient LH and FSH.

    • Weight retention/skin changes → suggest cortisol deficiency.

    • Fatigue → linked to low thyroid hormones.

  • Susceptibility of Pregnant Women to Pituitary Infarction: Increased blood supply during pregnancy can make pituitary tissue vulnerable.

  • Posterior Pituitary Affected: Damage may not be uniform across pituitary; often anterior lobe is significantly affected.

Prolactin Regulation and Stimulation

  • Hypothalamus: Prolactin induces dopamine synthesis.

  • Dopamine: Main inhibitory factor limiting prolactin production.

  • Thyrotropin-releasing hormone (TRH) stimulates prolactin release.

Stimulatory Factors

  • Pregnancy (induced by estrogen)

  • Breast-feeding

  • Sleep

  • Stress

  • TRH

Inhibitory Factors

  • Dopamine

  • Dopamine antagonists (such as bromocriptine)

  • Somatostatin

  • Prolactin (negative feedback)

Causes of Hyperprolactinemia

  • Physiologic Causes:

    • Pregnancy

    • Nipple stimulation

    • Stress

  • Pathologic Causes:

    • Lactotroph adenomas

    • Decreased dopaminergic inhibition due to hypothalamic or pituitary diseases.

    • Drug use (e.g., antipsychotics).

  • Other Causes:

    • Estrogen

    • Hypothyroidism

    • Chest wall injury

    • Chronic renal failure

    • Idiopathic hyperprolactinemia

    • Macroprolactinemia

    • Genetic causes.

Serum Prolactin Levels in Pregnancy and Breastfeeding

  • During pregnancy, increased levels of prolactin serve to suppress GnRH.

  • Serum prolactin levels change based on:

    • Pregnancy duration (higher in later months).

    • Lactation status postpartum.

Case #2: Eloise

  • Chief Complaint: Amenorrhea for 3 months post-motorcycle accident.

  • Patient Profile: 28-year-old female, has gained weight, drinks and urinates more than prior to the accident, reports galactorrhea.

  • Vital Signs: T 36.5°C, P 84/min, BP 95/60, BMI 29.

Eloise’s Laboratory Values

Test

Value

Normal Range

Pregnancy test

Negative

FSH

2 mIU/ml

4-30

LH

2 mIU/ml

5-30

Cortisol (8 AM)

2 mg/dL

5-25

TSH

0.2 mU/L

0.5-5

Thyroxine (T4)

3 mg/dL

5-12

Triiodothyronine (T3)

80 ng/dL

115-190

Prolactin

70 ng/mL

<20

Identifying the Cause of Hyperprolactinemia

  • Likely condition based on history and symptoms:

    • Ischemic necrosis of the pituitary.

    • Traumatic damage to the pituitary stalk.

    • Prolactinoma (adenoma of lactotropes).

    • Increased prolactin due to dopamine antagonist use.

    • Hypothyroidism.

Case #3: Megan

  • Chief Complaint: Irregular menses and missed periods.

  • Patient Profile: 30-year-old female not on hormonal contraception, normal onset of menstruation.

  • Physical Exam: Normal pelvic exam.

Megan’s Laboratory Values

Test

Value

Normal Range

Pregnancy test

Negative

FSH

2 mIU/ml

4-30

LH

2 mIU/ml

5-30

Cortisol (4 PM)

7 mg/dL

3-15

TSH

3.0 mU/L

0.5-5

Thyroxine (T4)

7 mg/dL

5-12

Triiodothyronine (T3)

150 ng/dL

115-190

Prolactin

220 ng/mL

5-25

Identifying Causes of Megan’s Hyperprolactinemia

  • Likely causes:

    • Ischemic necrosis of the pituitary.

    • Hypopituitarism due to damage to the pituitary stalk.

    • Prolactinoma (adenoma of lactotropes).

    • Increased prolactin due to a dopamine antagonist.

    • Hypothyroidism.

Identifying the Cause of Low Gonadotropin Levels in Megan

  • Causes of low LH and FSH:

    • Negative feedback due to high prolactin levels.

    • Negative feedback due to stress.

    • Loss of LH and FSH production due to lactotroph hyperplasia.

    • Negative feedback from elevated estrogen levels.

PRL Suppression of LH and FSH

  • Illustration of hormone dynamics:

    • Normal hormone profiles show suppression of LH and FSH by elevated prolactin levels.

Growth Hormone

  • Physiologic Role of GH varies with age; typically decreases with increasing age.

Correlation Between GH Levels and Age

  • GH secretion patterns demonstrate a peak during ages 3-5 years, tapering off in adulthood,

  • The clinical significance of GH levels includes growth velocity in children and impacts on metabolism in adults.

Clinical Cases of Acromegaly

  • 34-year-old Man: Increased shoe size, altered facial features, high IGF-1 and GH levels leading to a diagnosis of acromegaly.

  • 42-year-old Jeweler: Noted physical changes and bitemporal hemianopsia, MRI revealed macroadenoma with elevated GH levels.

Sam Atotrope - Findings

  • Fasting GH level: 56 ng/ml (normal: 0-5 ng/ml).

  • IGF-1: 988 ng/ml (normal: 90-360 ng/ml).

  • Glucose suppression test showed slow suppression (persisted elevated levels).

Metabolic Dysregulation in Acromegaly

  • Considerations for metabolic effects of excess GH:

  • Changes in fat, protein, and glucose metabolism correlate with the clinical features of acromegaly (visual changes, fatigue, increased appetite).

Treatment of Acromegaly

  • Treatment strategies include:

    • Surgical resection of the pituitary tumor.

    • Stereotactic radiotherapy.

    • Medical therapy with somatostatin analogues (e.g. octreotide) or GH receptor antagonists.

  • Note that while some symptoms may improve, skeletal changes are typically irreversible.

Diagnosis of Acromegaly

  1. Biochemical confirmation by measuring IGF-I levels.

  2. Oral glucose tolerance test for GH measurement indicating insufficient suppression.

  3. Follow-up with pituitary MRI.

Questions?